Predicting the immunogenicity of human leukocyte antigen class i alloantigens using structural epitope analysis determined by HLAMatchmaker

Transplantation

Volumn 85, Issue 12, 2008, Pages 1817-1825

  Kosmoliaptsis, Vasilis ^a,b   Bradley, J Andrew ^b   Sharples, Linda D ^c   Chaudhry, Afzal ^a   Key, Timothy ^a   Goodman, Reyna S ^a   Taylor, Craig J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Eplet mismatches; HLA immunogenicity; HLAMatchmaker; Triplet mismatches

Indexed keywords

ALLOANTIBODY; ALLOANTIGEN; EPITOPE; HLA A ANTIGEN; HLA ANTIBODY; HLA B ANTIGEN; AMINO ACID; ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SCREENING; ANTIBODY SPECIFICITY; ARTICLE; CLASSIFICATION ALGORITHM; CLINICAL ARTICLE; COMPUTER PROGRAM; FEMALE; HLA MATCHING; HUMAN; IMMUNOGENICITY; MALE; PRIORITY JOURNAL; SENSITIZATION; ALGORITHM; GENE; GENETICS; GRAFT REJECTION; IMMUNOGENETICS; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MIDDLE AGED; PREDICTION AND FORECASTING; STATISTICAL MODEL;

ADULT; ALGORITHMS; AMINO ACIDS; ANTIBODIES; EPITOPES; FEMALE; GENES, MHC CLASS I; GRAFT REJECTION; HUMANS; IMMUNOGENETICS; ISOANTIGENS; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 49149111790     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31817441d6     Document Type: Article

References (21)

1. Ting A, Morris PJ. Powerful effect of HLA-DR matching on survival of cadaveric renal allografts. Lancet 1980; 2: 282.
2. Persijn GG, Cohen B, Lansbergen Q, et al. Effect of HLA-A and HLA-B matching on survival of grafts and recipients after renal transplantation. N Engl J Med 1982; 307: 905.
3. Morris PJ, Johnson RJ, Fuggle SV, et al. Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA task force of the kidney advisory group of the United Kingdom Transplant Support Service Authority (UKTSSA). Lancet 1999; 354: 1147.
4. Opelz G, Wujciak T, Döhler B, et al. HLA compatibility and organ transplant survival. Collaborative transplant study. Rev Immunogenet 1999; 1: 334.
5. Cecka JM. The UNOS renal transplant registry. Clin Transpl 2002; 1.
6. OpelzG, DohlerB. Effect of human leukocyte antigen compatibility on kidney graft survival: Comparative analysis of two decades. Transplantation 2007; 84: 137.
7. Maruya E, Takemoto S, Terasaki PI. HLA matching: Identification of permissible HLA mismatches. Clin Transpl 1993; 25: 511.
8. Doxiadis II, Smits JMA, Schreuder GM, et al. Association between specific HLA combinations and probability of kidney allograft loss: The taboo concept. Lancet 1996; 348: 850.
9. Claas FH, Dankers MK, Oudshoorn M, et al. Differential immunogenicity of HLA mismatches in clinical transplantation. Transpl Immunol 2005; 14: 187.
10. Claas FHJ, Roelen DL, Mulder A, et al. Differential immunogenicity of HLA class I alloantigens for the humoral versus the cellular immune response: "Towards tailor-made HLA mismatching". Hum Immunol 2006; 67: 424.
11. Taylor CJ, Dyer PA. Maximizing the benefits of HLA matching for renal transplantation: Alleles, specificities, cregs, epitopes, or residues. Transplantation 1999; 68: 1093.
12. Duquesnoy RJ. HLAMatchmaker: A molecularly based donor selection algorithm for highly alloimmunized patients. Transplant Proc 2001; 33: 493.
13. Duquesnoy RJ. HLAMatchmaker: A molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Hum Immunol 2002; 63: 339.
14. Duquesnoy RJ, Marrari M. HLAMatchmaker: A molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. Hum Immunol 2002; 63: 353.
15. Duquesnoy RJ, Takemoto S, de Lange P, et al. HLAMatchmaker: A molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A, B amino acid triplet level on kidney transplant survival. Transplantation 2003; 75: 884.
16. Haririan A, Fagoaga O, Daneshvar H, et al. Predictive value of HLA epitope matching using HLAMatchmaker for graft outcomes in a predominantly African-American renal transplant cohort. Clin Transplant 2006; 20: 226.
17. Dankers MK, Witvliet MD, Roelen DL, et al. The numberof amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens. Transplantation 2004; 77: 1236.
18. Goodman RS, Taylor CJ, O'Rourke CM, et al. Utility of HLAMatchmaker and single-antigen HLA antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation. Transplantation 2006; 81: 1331.
19. Duquesnoy RJ. A structurally based approach to determine HLA compatibility at the humoral immune level. Hum Immunol 2006; 67: 847.
20. Duquesnoy RJ, Askar M. HLAMatchmaker: A molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP. Hum Immunol 2007; 68: 12.
21. Mizutani K, Terasaki P, Hamdani E, et al. The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients. Am J Transplant 2007; 7: 1027.